NOMID patients possess the NLRP3 gene (with point mutations) that encodes aberrant cryopyrin and promotes the formation of the hyperactive inflammasome and inappropriate production of active IL-1β, leading to amplification of inflammation—and even loss of control—following a series of manifestations of organ inflammation. This evidence concerns the gene IL1B and CINCA syndrome.